Dropprint Genomics
The better way to run single cell genomics
Y CombinatorWinter 2020AcquiredHealthcareDrug Discovery and DeliveryGenomics
What they do
Problem
Single-cell genomics is expensive and difficult to analyze at scale, limiting adoption and insight from cell-by-cell data.
Solution
They provide software and computational infrastructure for scalable single-cell genomics analysis while reducing sequencing cost by about 10x.
Who it's for
Researchers and biotech/pharma teams running single-cell sequencing experiments.
Founders
Rachel Gate
Founder
PhD bioinformatics (UCSF) | Cofounder of Dropprint Genomics (W20; acquired by Immunai) | Currently building out new businesses lines in biotech
Meena Subramaniam
Founder
Jimmie Ye
Founder
Company timeline
- YC batchWinter 2020
- StatusAcquired
- Team size2 people
- LocationSan Francisco, CA, USA
Similar startups
Deepcell
Integrated platform for imaging, AI-powered analysis and enrichment o…
Tamarind Bio
AI Inference Platform for Drug Discovery
Loop Genomics
Novel long-read DNA sequencing technology
Ultima Genomics
Novel DNA sequencing architecture to scale the ultra low cost whole g…
Transcriptic
The robotic cloud laboratory for the life sciences.
XGenomes
XGenomes is building the sequencing technology of the future.